Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Protagonist Therapeutics Secures Breakthrough Therapy Designation for Rusfertide in Polycythaemia Vera
Tuesday, August 26, 2025Protagonist Therapeutics has announced that its investigational therapy rusfertide a firstinclass hepcidinmimetic peptide has been granted Breakthrough Therapy Designation by the US Food and Drug Administration FDA for the treatment of erythrocytosis...
BioArctic Signs USD 30 Million Collaboration Agreement with Novartis for BrainTransporter™
Tuesday, August 26, 2025BioArctic AB has signed an option collaboration and licence agreement with Novartis Pharma AG to develop a potential treatment that combines BioArctics BrainTransporter technology with a Novartis antibody for neurodegenerative diseases
MannKind to Acquire scPharmaceuticals to Strengthen Position in Cardiometabolic and Lung Diseases
Tuesday, August 26, 2025MannKind has entered into a definitive agreement to acquire scPharmaceuticals in a move aimed at expanding its focus on cardiometabolic and orphan lung diseases
Genentech and Roche Begin Construction of New Manufacturing Site in North Carolina
Tuesday, August 26, 2025Genentech part of the Roche Group has started construction of a major manufacturing facility in Holly Springs North CarolinaThis will be the companys first manufacturing site on the East Coast of the United States
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts
Monday, August 25, 2025Cambrex has expanded the peptide development and manufacturing capacity of its subsidiary Snapdragon Chemistry at Waltham Massachusetts
Johnson & Johnson Commits $2 Billion for Manufacturing Expansion in North Carolina
Friday, August 22, 2025Johnson Johnson has announced a billion investment to expand its US manufacturing network through a new facility in Holly Springs North Carolina
Ionis Pharmaceuticals Receives Approval for DAWNZERA™, the First RNA-Targeted Prophylactic Treatment for Hereditary Angioedema
Friday, August 22, 2025Ionis Pharmaceuticals has announced that the US Food and Drug Administration FDA has approved DAWNZERA donidalorsen for the prevention of hereditary angioedema HAE attacks in adults and adolescents aged years and above
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
Friday, August 22, 2025Kite a Gilead company has announced an agreement to acquire Interius BioTherapeutics for million
Crinetics Receives FDA Orphan Drug Designation for Atumelnant in Congenital Adrenal Hyperplasia
Friday, August 22, 2025Crinetics Pharmaceuticals has received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for atumelnant a oncedaily oral adrenocorticotropic hormone ACTH receptor antagonist
Keros Receives U.S. FDA Orphan Drug Designation for KER-065 in Duchenne Muscular Dystrophy
Thursday, August 21, 2025Keros Therapeutics has received Orphan Drug designation from the US Food and Drug Administration FDA for its investigational therapy KER developed for the treatment of Duchenne muscular dystrophy DMD
